Evidence map›Paper›PMID 28862678›Full record

ReviewNutrients2017

Rosemary Extract as a Potential Anti-Hyperglycemic Agent: Current Evidence and Future Perspectives.

Madina Naimi, Filip Vlavcheski, Hesham Shamshoum, Evangelia Tsiani

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 117 citations in OpenAlex.

  1. Article
  2. Review
  3. Biological functions and applications of rosemary extracts in animal production.Animal nutrition (Zhongguo xu mu shou yi xue hui) · 2026
    Review
  4. Article
  5. Active Packaging Films from PBAT/PLA withMolecules (Basel, Switzerland) · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Nutrients · 2022
    Article
  17. The Antioxidant Activity ofAntioxidants (Basel, Switzerland) · 2022
    Article
  18. Article
  19. African health sciences · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Madina NaimiDepartment of Health Sciences, Brock University, St. Catharines, ON L2S 3A1, Canada. madinanaimi@gmail.com.
Filip VlavcheskiDepartment of Health Sciences, Brock University, St. Catharines, ON L2S 3A1, Canada. fv11vi@brocku.ca.
Hesham ShamshoumDepartment of Health Sciences, Brock University, St. Catharines, ON L2S 3A1, Canada. hs12af@brocku.ca.
Evangelia TsianiDepartment of Health Sciences, Brock University, St. Catharines, ON L2S 3A1, Canada. ltsiani@brocku.ca.
Brock University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 2 diabetes mellitus (T2DM), a disease on the rise and with huge economic burden to health care systems around the globe, results from defects in insulin action (termed insulin resistance) combined with impaired insulin secretion. Current methods of prevention and treatments for insulin resistance and T2DM are lacking in number and efficacy and, therefore, there is a need for new preventative measures and targeted therapies. In recent years, chemicals found in plants/herbs have attracted attention for their use as functional foods or nutraceuticals for preventing and treating insulin resistance and T2DM. Rosemary is an evergreen shrub indigenous to the Mediterranean region and South America, which contains various polyphenols. Rosemary extract and its polyphenolic constituents have been reported to have antioxidant, anti-inflammatory, anticancer, and anti-hyperglycemic properties. The current review summarizes the existing in vitro and in vivo studies examining the anti-diabetic effects of rosemary extract and its polyphenolic components and highlights the known mechanism of action.

Indexed as

Diabetes Mellitus, Type 2HumansHyperglycemiaInsulin ResistancePlant ExtractsRosmarinusPlant Extractscarnosic acidcarnosoldiabetesinsulin resistancerosemary extractrosmarinic acid

Identifiers

PMID28862678
PMCPMC5622728
OpenAlexW2751672023

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.